Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2007
Business Overview: The Company develops, manufactures, and markets disposable protective apparel, infection control products, construction weatherization products, and extended care products (medical bed pads and pet beds). Operations are divided into four segments: Disposable Protective Apparel, Infection Control, Engineered Products, and Extended Care.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Sales | $9,044,000 | $7,971,000 |
| Gross Margin | $4,164,000 (46.0%) | $3,641,000 (45.7%) |
| Operating Income | $826,000 | $1,034,000 |
| Net Income | $535,000 | $649,000 |
| Diluted EPS | $0.02 | $0.03 |
| Cash and Equivalents (End of Period) | $1,086,000 | $882,000 |
| Working Capital | $20,921,000 | N/A |
| Debt | $0 | $0 |
Liquidity: The Company maintains a $3,500,000 line of credit with no borrowings outstanding as of March 31, 2007. The current ratio improved to 11.48:1 from 8.32:1 at year-end 2006.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 13.5% ($1.073 million) driven by a 32.1% surge in the Disposable Protective Apparel segment and a 19.5% increase in Infection Control sales.
- Segment Declines: Engineered Products sales dropped 26.2% due to a strategic shift away from an exclusive distributor (Perma R), and Extended Care sales fell 21.8% due to lower medical bed pad demand.
- Profitability: Despite revenue growth, Operating Income decreased 20.1% to $826,000. This was caused by a 29.1% increase in Selling, General, and Administrative (SG&A) expenses, largely attributed to marketing campaigns for new construction products and increased sales team costs.
- Cash Flow: Net cash used in operating activities increased significantly to $1.383 million (from $515,000 used in Q1 2006), primarily due to a $2.067 million increase in inventory levels to support sales growth.
Outlook, Risks, and Management Commentary
- Strategic Shifts: Management expects the Engineered Products segment to contribute to revenue growth in 2007 following the launch of new products (REX Synfelt and REX Wrap) and a move to a non-exclusive distribution model, though short-term sales may remain affected.
- Market Conditions: Sales of N-95 Respirator masks are expected to be weaker in 2007 as concerns regarding Avian Flu have abated. The Extended Care segment is not expected to be a growth driver.
- Cost Structure: Management believes the infrastructure is in place to grow the business and expects SG&A expenses to decrease as a percentage of sales as revenue expands.
- Risks: The Company faces foreign currency exchange risks due to subcontracting in China and Mexico and a joint venture in India. It does not hedge these risks. Inventory valuation risks exist if market conditions deteriorate.
- Accounting Updates: The Company adopted FIN 48 (Accounting for Uncertainty in Income Taxes) on January 1, 2007, with no material impact on unrecognized tax benefits.
Investor Verification Checklist
- Inventory Build-up: Verify the necessity of the $2.067 million inventory increase and assess the risk of obsolescence, particularly in the Engineered Products segment.
- SG&A Efficiency: Monitor whether SG&A expenses stabilize as a percentage of sales in subsequent quarters following the heavy marketing spend in Q1.
- Distributor Transition: Track the success of the new non-exclusive distribution strategy for Engineered Products to ensure the loss of the Perma R contract is offset by new sales.
- Cash Burn: Review the trend of negative operating cash flow ($1.383 million used) to ensure it is temporary and driven by strategic inventory stocking rather than operational inefficiency.
- Joint Venture Performance: Monitor the financial health and repayment schedule of the Harmony Plastics Private Limited joint venture in India.